Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Clinical trial NCT05464810 · RECRUITING

Trial details

NCT number: NCT05464810
Sponsor: Emory University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 HER2-Negative Breast Carcinoma Hormone Receptor-Positive Breast Carcinoma Invasive Breast Carcinoma

Start date: 2022-09-02
Primary completion: 2027-04-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.